Loading clinical trials...
Loading clinical trials...
Type 1 myotonic dystrophy (MD1) is a genetic and hereditary disease that primarily affects muscle tissue, resulting in myotonia (difficulty relaxing after contraction) and atrophy (progressive muscle ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Hospitalier Universitaire de Nice
NCT06300307 · Myotonic Dystrophy 1
NCT05532813 · Steinert's Disease, Myotonic Dystrophy 1, and more
NCT07136844 · Neuromuscular Diseases, Obesity (Disorder), and more
NCT02398786 · Myotonic Dystrophy, Congenital Myotonic Dystrophy, and more
NCT07008469 · Myotonic Dystrophy Type 1, DM1, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions